Your browser is no longer supported. Please, upgrade your browser.
Settings
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E76.57 EPS (ttm)2.51 Insider Own0.10% Shs Outstand37.77M Perf Week-1.69%
Market Cap7.26B Forward P/E37.41 EPS next Y5.14 Insider Trans0.00% Shs Float37.62M Perf Month-0.84%
Income96.70M PEG7.02 EPS next Q1.15 Inst Own95.70% Short Float1.47% Perf Quarter32.16%
Sales681.70M P/S10.66 EPS this Y20.40% Inst Trans-0.75% Short Ratio2.64 Perf Half Y-3.15%
Book/sh29.03 P/B6.63 EPS next Y14.35% ROA5.60% Target Price203.25 Perf Year29.57%
Cash/sh4.14 P/C46.41 EPS next 5Y10.91% ROE8.90% 52W Range132.75 - 206.04 Perf YTD32.90%
Dividend1.28 P/FCF68.40 EPS past 5Y-4.30% ROI6.10% 52W High-6.65% Beta1.24
Dividend %0.67% Quick Ratio3.30 Sales past 5Y15.70% Gross Margin66.50% 52W Low44.89% ATR3.76
Employees2000 Current Ratio4.30 Sales Q/Q13.20% Oper. Margin19.00% RSI (14)53.10 Volatility2.41% 1.92%
OptionableYes Debt/Eq0.50 EPS Q/Q12.00% Profit Margin14.10% Rel Volume0.92 Prev Close200.44
ShortableYes LT Debt/Eq0.49 EarningsFeb 05 BMO Payout49.90% Avg Volume209.32K Price192.34
Recom1.90 SMA20-1.22% SMA505.77% SMA20011.46% Volume193,460 Change-4.04%
Jan-14-19Upgrade Stephens Equal-Weight → Overweight
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Apr-18-08Downgrade Robert W. Baird Outperform → Neutral $71
Sep-07-07Downgrade Leerink Swann Outperform → Mkt Perform
Jan-31-07Downgrade First Analysis Sec Overweight → Equal-Weight
Mar-05-19 09:08AM  Bio-Techne Scores A Trio Of CiteAb 2019 Awards PR Newswire
08:08AM  Bio-Techne To Present At The Barclays Global Healthcare Conference PR Newswire
Mar-04-19 07:15AM  Report: Exploring Fundamental Drivers Behind Stericycle, B&G Foods, QTS Realty Trust, Trimble, Electronics for Imaging, and Bio-Techne New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-26-19 01:18PM  Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics PR Newswire
Feb-20-19 09:15AM  Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-14-19 08:48AM  Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines Zacks
Feb-07-19 10:54PM  Edited Transcript of TECH earnings conference call or presentation 5-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Feb-05-19 07:29PM  Bio-Techne Corp (TECH) Q2 2019 Earnings Conference Call Transcript Motley Fool +6.07%
07:45AM  Techne (TECH) Q2 Earnings and Revenues Surpass Estimates Zacks
06:30AM  Bio-Techne Releases Second Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Feb-01-19 10:30AM  What Bio-Techne Corporations (NASDAQ:TECH) ROE Can Tell Us Simply Wall St.
Jan-31-19 02:26PM  ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection PR Newswire
Jan-29-19 10:31AM  Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for Zacks
10:29AM  Avalon GloboCare Stock Is an Expensive Mystery InvestorPlace
09:00AM  Bio-Techne Introduces 48-Digoxigenin Cartridge for the Ella Platform PR Newswire
Jan-28-19 09:15AM  Bio-Techne Introduces CE-SDS PLUS for Maurice System PR Newswire
Jan-25-19 02:41PM  5 Innovation-Led Stocks For The Health Care Boom Investopedia
Jan-24-19 09:00AM  Bio-Techne Launches Cell and Gene Therapy Portfolio PR Newswire
Jan-18-19 08:00PM  Five Ways to Profit from the Boom in Life Science Barrons.com
Jan-16-19 09:00AM  Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results PR Newswire
Jan-14-19 09:30AM  ANIK or TECH: Which Is the Better Value Stock Right Now? Zacks
Jan-02-19 08:19AM  Does Bio-Techne Corporation (NASDAQ:TECH) Have A Good P/E Ratio? Simply Wall St.
Dec-20-18 09:15AM  Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-18-18 03:04AM  Hedge Funds Are Crazy About Bio-Techne Corporation (TECH) Insider Monkey
Dec-06-18 12:14PM  Should You Think About Buying Bio-Techne Corporation (NASDAQ:TECH) Now? Simply Wall St.
Dec-04-18 09:15AM  Bio-Techne Releases GMP ROCK Inhibitor and CHIR 99021 for Stem Cell Therapy PR Newswire
Nov-20-18 09:15AM  Bio-Techne To Present At The Citi 2018 Global Healthcare Conference PR Newswire
06:31AM  New Strong Sell Stocks for November 20th Zacks
Nov-08-18 05:05PM  The List: Corporate board pay climbing? Not in Minnesota at least not this year American City Business Journals
Nov-03-18 06:16PM  Edited Transcript of TECH earnings conference call or presentation 30-Oct-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 07:30AM  Report: Exploring Fundamental Drivers Behind Equity Lifestyle Properties, AvalonBay Communities, Kadant, Mastercard, Bio-Techne, and Erie Indemnity New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-31-18 12:42PM  What Did Bio-Techne Corporations (NASDAQ:TECH) CEO Take Home Last Year? Simply Wall St.
Oct-30-18 02:54PM  Bio-Techne Corp (TECH) Q1 2019 Earnings Conference Call Transcript Motley Fool -6.26%
07:00AM  Bio-Techne Releases First Quarter Fiscal 2019 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
Oct-26-18 09:15AM  Bio-Techne To Present At The 2018 Stephens NY Investment Conference PR Newswire
Oct-18-18 11:01AM  Bio-Techne Partners Micropoint Bioscience, Expands in China Zacks
Oct-12-18 08:30AM  Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience PR Newswire
Oct-11-18 09:00AM  Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results PR Newswire
Oct-05-18 08:36AM  How Do Analysts See Bio-Techne Corporation (NASDAQ:TECH) Performing In The Next Couple Of Years? Simply Wall St.
Oct-02-18 09:15AM  Bio-Techne Scientist Presented with the CASSS CE Pharm Award PR Newswire
Oct-01-18 03:07PM  Edited Transcript of TECH earnings conference call or presentation 7-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Sep-27-18 09:15AM  Bio-Techne Announces Cell and Gene Therapy Initiative PR Newswire
Sep-19-18 09:15AM  Bio-Techne Supports International Antibody Validation Meetings PR Newswire
Sep-18-18 12:02PM  Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal PR Newswire
Sep-11-18 08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
Sep-06-18 09:15AM  Bio-Techne Fills a Need for Simple Tools to Study Glycobiology PR Newswire
Sep-05-18 10:00AM  Bio-Techne To Present At The Morgan Stanley 16th Annual Global Healthcare Conference PR Newswire
Aug-31-18 10:40AM  Bio-Techne Corporation (NASDAQ:TECH): Set To Experience A Decrease In Earnings? Simply Wall St.
Aug-28-18 10:00AM  Bio-Techne To Present At The Baird 2018 Global Healthcare Conference PR Newswire
Aug-27-18 06:48PM  Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2018 GuruFocus.com
Aug-08-18 09:00AM  Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development PR Newswire
Aug-07-18 07:00AM  Bio-Techne Releases Fourth Quarter Fiscal 2018 Results PR Newswire +6.69%
07:00AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Aug-02-18 09:00AM  Bio-Techne Announces 2018 Investor Day And Webcast PR Newswire
Aug-01-18 04:15PM  Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc. PR Newswire
08:30AM  Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-24-18 08:00AM  Bio-Techne Introduces New Member of the Simple Western Family, with IR/NIR Detection Capabilities PR Newswire
Jul-12-18 05:52PM  5 Tips for Making Money in Penny Stocks InvestorPlace
09:00AM  Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results PR Newswire
Jul-10-18 08:00AM  Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets PR Newswire
Jun-26-18 10:00AM  Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs PR Newswire
Jun-25-18 04:09PM  Bio-Techne To Acquire Exosome Diagnostics, Inc. PR Newswire
Jun-22-18 07:47AM  Is Bio-Techne Corporation (NASDAQ:TECH) A Financially Strong Company? Simply Wall St.
Jun-07-18 08:00AM  Bio-Techne To Acquire Quad Technologies PR Newswire
Jun-04-18 10:00AM  Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference PR Newswire
May-24-18 10:00AM  Bio-Techne To Present At The Jefferies 2018 Healthcare Conference PR Newswire
May-16-18 08:00AM  Better Know Biotech: 2 Stocks You Ought to Know About Motley Fool
May-10-18 10:00AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-07-18 02:19PM  When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)? Simply Wall St.
May-03-18 10:05PM  Edited Transcript of TECH earnings conference call or presentation 2-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-02-18 10:18AM  Does Bio-Techne Corporations (NASDAQ:TECH) PE Ratio Warrant A Sell? Simply Wall St.
07:00AM  Bio-Techne Releases Third Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
May-01-18 10:00AM  Bio-Techne To Present At The Deutsche Bank 43rd Annual Health Care Conference PR Newswire
Apr-26-18 01:00PM  Bio-Techne Leads the Way in Scientific Support for Autophagy Research PR Newswire
Apr-24-18 04:15PM  Bio-Techne Announces New Leadership Appointment PR Newswire
Apr-18-18 07:55AM  New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-29-18 07:45AM  New Research: Key Drivers of Growth for Bio-Techne, QTS Realty Trust, CYS Investments, Prologis, Gramercy Property Trust, and NanoString Technologies Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-22-18 08:44AM  3 Reasons Momentum Stock Investors Will Love Bio-Techne (TECH) Zacks
Mar-21-18 01:00PM  Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development PR Newswire
Mar-15-18 08:00AM  10 Growth Stocks for Long-Term Investors Investopedia
Mar-14-18 01:00PM  Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract PR Newswire
Feb-14-18 07:50AM  Blog Exposure - AVEO Announced Positive NICE Recommendation for FOTIVDA(R) as First Line Treatment for Advanced Renal Cell Carcinoma ACCESSWIRE
Feb-09-18 04:55AM  Edited Transcript of TECH earnings conference call or presentation 6-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
Feb-07-18 09:00AM  Bio-Techne Named "Researchers' Choice" by CiteAb PR Newswire
Feb-06-18 11:39AM  What does Bio-Techne Corporations (NASDAQ:TECH) Balance Sheet Tell Us About Its Future? Simply Wall St.
09:25AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Releases Second Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Feb-05-18 08:00AM  Bio-Techne To Present At The Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
Jan-30-18 05:11PM  Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms PR Newswire
Jan-26-18 07:40AM  Research Report Identifies Methode Electronics, Bio-Techne, VOXX International, American Tower Corporation (REIT), Medical Properties Trust, and HRG Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-24-18 07:02AM  The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Bio-Techne, Exelixis, Paratek and Bioverativ Zacks
Jan-18-18 07:30AM  Bio-Techne To Host Conference Call On February 6, 2018 To Announce Second Quarter 2018 Financial Results PR Newswire
Jan-15-18 09:00AM  Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne PR Newswire
08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Jan-02-18 05:01PM  Bio-Techne Acquires Atlanta Biologicals Inc. PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents. It also provides various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, such as cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Protein Platforms segment offers Biologics tools for researchers to interrogate protein purity and identify contaminants during the development and production of biologics; Western blot, an assay for protein analysis and identification; SimplePlex platform, an enzyme-linked immunosorbent assay for use in research and clinical diagnostics; and Single Cell Western platform to elucidate the properties of individual cells to understand cell behavior. The Diagnostics segment provides blood chemistry and gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market. Bio-Techne Corporation has a strategic cooperation agreement with Micropoint Bioscience. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUMGARTNER ROBERT VDirectorAug 24Option Exercise61.465,000307,30012,712Aug 28 05:30 PM
BAUMGARTNER ROBERT VDirectorAug 24Sale188.475,000942,3347,712Aug 28 05:30 PM
HIGGINS JOHN LDirectorAug 23Option Exercise61.0810,000610,80013,012Aug 27 04:12 PM
HIGGINS JOHN LDirectorAug 23Sale187.9210,0001,879,1733,012Aug 27 04:12 PM
Dinarello Charles ADirectorAug 08Option Exercise63.035,000315,15013,212Aug 10 04:18 PM
Dinarello Charles ADirectorAug 08Sale176.945,000884,6758,212Aug 10 04:18 PM
Eansor Norman DavidSVP - Novus BiologicalsAug 07Option Exercise0.001,19903,465Aug 09 06:29 PM
Furlow Brenda S.SVP - General CounselAug 07Option Exercise0.0095902,627Aug 09 06:26 PM
Hippel JamesChief Financial OfficerAug 07Option Exercise0.002,39805,477Aug 09 06:19 PM
Kummeth Charles R.Chief Executive OfficerAug 07Option Exercise0.0013,816090,288Aug 09 07:22 PM
Kummeth Charles R.Chief Executive OfficerJun 07Sale160.008,0001,280,00076,472Jun 08 04:21 PM
Eansor Norman DavidSVP - Novus BiologicalsMay 04Sale145.191,136164,9322,266May 11 04:16 PM